$49.89 +0.45 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - NYSE

Apr. 1, 2015 | 12:20 PM

Partner Headlines

  1. Dodge & Cox 2014 Equity Year in Review

    GuruFocus | Feb. 19, 2015 | 18:29PM EST
  2. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  3. ENGAGE Randomized Clinical Trial Evaluating Cerdelgafor Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association

    Benzinga | Feb. 17, 2015 | 11:36AM EST
  4. Making Money With Charles Payne: 02/13/15

    FoxBusiness | Feb. 13, 2015 | 18:00PM EST
  5. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  6. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  7. Sanofi Posts Higher Q4 Profit

    Benzinga | Feb. 5, 2015 | 05:22AM EST
  8. Fourth Quarter Was Barrow's Slowest Since 2012

    GuruFocus | Feb. 4, 2015 | 17:48PM EST
  9. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  10. Making Money With Charles Payne: 01/19/15

    FoxBusiness | Jan. 19, 2015 | 18:00PM EST
  11. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  12. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  13. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  14. Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  15. Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  16. Guru Stocks at 52-Week Lows: GOOG, VZ, HSBC, SNY, TOT

    GuruFocus | Jan. 12, 2015 | 10:35AM EST
  17. Regeneron rises on drug data

    IBD | Jan. 9, 2015 | 18:42PM EST
  18. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD | Jan. 9, 2015 | 15:42PM EST
  19. Indexes Slump As Employment Data, Falling Oil Weigh

    IBD | Jan. 9, 2015 | 15:13PM EST
  20. Stocks Stay In Red; Acuity Soars On Strong LED Demand

    IBD | Jan. 9, 2015 | 13:29PM EST
  21. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD | Jan. 9, 2015 | 11:52AM EST
  22. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  23. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  24. SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi ...

    GuruFocus | Jan. 2, 2015 | 15:02PM EST
  25. Guru Stocks at 52-Week Lows: HSBC, SNY, WBK, DCM, BBVA

    GuruFocus | Dec. 23, 2014 | 10:57AM EST
  26. Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

    Benzinga | Dec. 12, 2014 | 08:04AM EST
  27. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  28. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  29. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  30. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  31. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  32. Morning Market Losers

    Benzinga | Dec. 1, 2014 | 09:53AM EST
  33. Pharma drugs advance in EU

    IBD | Nov. 21, 2014 | 18:19PM EST
  34. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  35. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  36. Asthma treatment passes trial

    IBD | Nov. 11, 2014 | 18:30PM EST
  37. Guru Stocks at 52-Week Lows: IBM, SNY, SAN, RIO, E

    GuruFocus | Nov. 9, 2014 | 01:58AM EST
  38. Guru Stocks at 52-Week Lows: IBM, BBL, SNY, SAN, RIO

    GuruFocus | Nov. 4, 2014 | 14:23PM EST
  39. Benzinga's M&A Chatter for Thursday October 30, 2014

    Benzinga | Oct. 30, 2014 | 21:24PM EST
  40. CNBC's Stock Pops & Drops From October 29

    Benzinga | Oct. 29, 2014 | 20:29PM EST
  41. Sanofi fires CEO, downgraded

    IBD | Oct. 29, 2014 | 18:41PM EST
  42. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD | Oct. 29, 2014 | 12:51PM EST
  43. Deutsche Bank Downgrades Sanofi SA

    Benzinga | Oct. 29, 2014 | 12:29PM EST
  44. Mid-Morning Market Update: Markets Mixed; Goodyear Earnings Beat Estimates

    Benzinga | Oct. 29, 2014 | 10:43AM EST
  45. Sanofi Warns Of Flat Growth

    IBD | Oct. 28, 2014 | 18:46PM EST
  46. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  47. Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

    Benzinga | Oct. 28, 2014 | 15:39PM EST
  48. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD | Oct. 28, 2014 | 14:42PM EST
  49. Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline

    Benzinga | Oct. 28, 2014 | 13:50PM EST
  50. Midday Losers From October 28: Twitter, Kohl's, Amkor Technologies And More

    Benzinga | Oct. 28, 2014 | 13:27PM EST
Trading Center